APA (7th ed.) Citation

WS, E. N., M, A. A., E, A., R, E. L., D, A., IM, G., . . . J, M. (2024). Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy. Antibiotics (Basel, Switzerland), 13(8), . https://doi.org/10.3390/antibiotics13080699

Chicago Style (17th ed.) Citation

WS, El Nekidy, et al. "Clinical Outcomes of Ceftazidime-Avibactam Versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy." Antibiotics (Basel, Switzerland) 13, no. 8 (2024). https://doi.org/10.3390/antibiotics13080699.

MLA (9th ed.) Citation

WS, El Nekidy, et al. "Clinical Outcomes of Ceftazidime-Avibactam Versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy." Antibiotics (Basel, Switzerland), vol. 13, no. 8, 2024, https://doi.org/10.3390/antibiotics13080699.